Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Maintanance therapy for stage 4 NSCLC
|
|
Definition
|
|
Term
List 2 differences of NSCLC |
|
Definition
- More common
- Slower growing
|
|
|
Term
List 2 differences of SCLC |
|
Definition
- Faster growing
- Paraneoplastic syndromes more common
|
|
|
Term
|
Definition
- Palonosetron 0.25mg IV
- Aprepatent 125mg PO
- Dexamethasone 8mg PO
the paleontologist did a preperatry map |
|
|
Term
|
Definition
|
|
Term
What is the black box warning on ESAs? |
|
Definition
Increased thrombotic events, CI if the intent is curative |
|
|
Term
Palifermin
- Criteria for treating mucositis
|
|
Definition
|
|
Term
|
Definition
- PCA
- Cryotherapy
- good oral hygiene
|
|
|
Term
Which drug classes are NOT cycle specific?
|
|
Definition
- Topo inhibitors
- Anthracyclines
- DNA binders
- Platinums
|
|
|
Term
|
Definition
|
|
Term
ECOG
- High functionality
- Low functionality
|
|
Definition
|
|
Term
Karnofskey score
- High functionality
- Low functionality
|
|
Definition
|
|
Term
|
Definition
- Palonosetron 0.25mg IV
- Dexamethasone 8mg PO
|
|
|
Term
|
Definition
|
|
Term
|
Definition
- K,P,uric acid
- Ca
- renal failure
(local) |
|
|
Term
|
Definition
- Enlarged prostate
- bicycle
- testosterone
|
|
|
Term
|
Definition
|
|
Term
Treating premenopausal breast cancer |
|
Definition
|
|
Term
Treating postmenopausal women |
|
Definition
|
|
Term
Adjuvent for breast cancer |
|
Definition
|
|